In vitro volatile exometabolome signature of clear cell renal cell carcinoma

被引：0
|
作者：
Amaro, F. S. [1 ]
Pinto, J. [1 ]
Rocha, S. [1 ]
Araujo, A. M. [1 ]
Goncalves, V. M. [2 ]
Jeronimo, C. [2 ,3 ,4 ]
Henrique, R. [3 ,4 ,5 ]
Bastos, M. D. L. [1 ]
Carvalho, M. [1 ,6 ]
Pinho, P. G. D. [1 ]
机构：
[1] Univ Porto, Dept Biol Sci, Toxicol Lab, UCIBIO REQUIMTE,Fac Pharm, Porto, Portugal
[2] IPO Porto Res Ctr, Canc Biol & Epigenet Grp, Porto, Portugal
[3] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, Porto, Portugal
[4] IPO Porto Res Ctr, Porto Comprehens Canc Ctr, Porto, Portugal
[5] Portuguese Oncol Inst Porto, Dept Pathol, Porto, Portugal
[6] UFP Energy, Environm & Hlth Res Unit, Porto, Portugal
来源：
TOXICOLOGY LETTERS | 2021年 / 350卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P04-45
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [41] Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
    Zhang, Fan
    Lin, Junyu
    Feng, Dechao
    Liang, Jiayu
    Lu, Yiping
    Liu, Zhihong
    Wang, Xianding
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [42] A signature based on chromatin regulation and tumor microenvironment infiltration in clear cell renal cell carcinoma
    Yang, Chen
    Yu, Tian
    Lin, Qin
    EPIGENOMICS, 2022, 14 (17) : 995 - 1014
  • [43] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Tian, X.
    Shuxuan, Z.
    Qu, Y.
    Hailiang, Z.
    Dingwei, Y.
    EUROPEAN UROLOGY, 2024, 85 : S1055 - S1055
  • [44] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Tian, Xi
    Zhu, Shuxuan
    Liu, Wangrui
    Wu, Xinrui
    Wei, Gaomeng
    Zhang, Ji
    Anwaier, Aihetaimujiang
    Chen, Cong
    Ye, Shiqi
    Che, Xiangxian
    Xu, Wenhao
    Qu, Yuanyuan
    Zhang, Hailiang
    Ye, Dingwei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (19) : 17451 - 17466
  • [45] Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma
    Lv, Yang
    Niu, Lili
    Li, Qiang
    Shao, Wenchuan
    Yan, Xinghan
    Li, Yang
    Yue, Yulin
    Chen, Hongqi
    AGING-US, 2024, 16 (03): : 2232 - 2248
  • [46] Prognostic value of tissue-based biomarker signature in clear cell renal cell carcinoma
    Haddad, Ahmed Q.
    Luo, Jun-Hang
    Krabbe, Laura-Maria
    Darwish, Oussama
    Gayed, Bishoy
    Youssef, Ramy
    Kapur, Payal
    Rakheja, Dinesh
    Lotan, Yair
    Sagalowsky, Arthur
    Margulis, Vitaly
    BJU INTERNATIONAL, 2017, 119 (05) : 741 - 747
  • [47] Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma
    Zhang, Chuanjie
    Qi, Feng
    Zheng, Yuxiao
    Xia, Xin
    Li, Xiao
    Wang, Xinwei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Identification of Crotonylation Metabolism Signature Predicting Overall Survival for Clear Cell Renal Cell Carcinoma
    Zheng, Jie
    Liu, Yingqing
    Wei, Kai
    Shi, Jiewu
    Li, Lin
    Jiang, Xuefeng
    Tao, Lingsong
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2023, 2023
  • [49] A Specific Gene Expression Signature Characterizes Metastatic Potential in Clear Cell Renal Cell Carcinoma
    Sanjmyatav, Jimsgene
    Steiner, Thomas
    Wunderlich, Heiko
    Diegmann, Julia
    Gajda, Mieczyslaw
    Junker, Kerstin
    JOURNAL OF UROLOGY, 2011, 186 (01): : 289 - 294
  • [50] Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
    Ma, Wei
    Zhong, Manli
    Liu, Xiaowu
    BIOSCIENCE REPORTS, 2021, 41 (08)
12345